Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 26 September 2025 - 27 September 2025

1-Million-Year-Old Skull Found in China Could Rewrite Human Evolution

1-Million-Year-Old Skull Found in China Could Rewrite Human Evolution

These key points set the stage for a detailed exploration of the new study and its implications. In the sections below we explain the discovery and reconstruction of the skull, compare it with other recent finds, and examine what experts are saying about how it might upend our understanding of human origins. The Yunxian 2 Skull: Discovery and Digital Reconstruction The fossil at the heart of this story is the Yunxian 2 cranium, unearthed in 1990 from a river terrace in Yunxian (Hubei). For decades the specimen sat in a museum, considered an indeterminate Homo erectus fossil because it was
27 September 2025
Iran’s Rial Crisis Deepens: USD Soars Past 1.08 Million on Black Market Amid Sanctions Fears (قیمت دلار)

Iran’s Rial Crisis Deepens: USD Soars Past 1.08 Million on Black Market Amid Sanctions Fears (قیمت دلار)

Official vs. Black-Market Rates in Iran Iran’s currency regime is highly tiered. State-backed exchange systems (for imports of essentials) quoted about 561,700 rials per $1 on Sept 27 trend.az. In currency shops (the SANA system) and the NIMA forex platform, $1 was around 692,500–719,800 rials during Sep 25–27 trend.az trend.az. By contrast, the free (open) market rate was vastly weaker – ~1,050,000–1,085,000 rials per $1. Bonbast and alanchand trackers showed prices spiking to ~1,085,500 IRR (108,550 tomans) on Sept 26 intellinews.com criticalthreats.org and holding above 1.08 million on Sept 27 trend.az trend.az. In short, Iranians needed roughly twice as many
27 September 2025
PACS Group (NYSE:PACS) Pops After NYSE Reprieve—Is the Nursing‑Home Giant Finally Turning the Corner? [Sep 26, 2025]

PACS Group (NYSE:PACS) Pops After NYSE Reprieve—Is the Nursing‑Home Giant Finally Turning the Corner? [Sep 26, 2025]

Key facts (as of Sep 26, 2025) In‑depth report What moved the stock this week PACS rallied into the Sep 26 close with intraday gains reported by market trackers. The surge follows two mid‑September catalysts: (1) NYSE’s listing extension to Nov 19, 2025, giving the company runway to finish restatements and regain compliance; and (2) a series of governance actions, including a CFO change. MarketBeat+2MarketBeat+2 Management messaging turned incrementally constructive. CEO Jason Murray said PACS expects to report “record revenue and Adjusted EBITDA for the first six months of 2025” once filings are current. Interim Chief Compliance Officer Kathy Lauer added that PACS is “taking the right steps to best position the company” during
26 September 2025
Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update

Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update

Stock Price Performance (YTD & Recent) Crinetics stock has been volatile but trending upward in 2025, with the recent FDA catalyst propelling it sharply higher. On September 26, 2025, CRNX closed around $45–$46, up roughly +28% in a single day reuters.com. This spike followed the Palsonify approval news and likely a short squeeze, given the high short interest (~14 million shares short, ~15.5% of float) prior to the decision marketbeat.com marketbeat.com. The one-year trading range spans $24.10 – $62.53 marketbeat.com, meaning the stock is now nearly double its 52-week low and about 26% below its 2023 high. In other words,
26 September 2025
·
Mirion Technologies (MIR) Surges on $585 Million Nuclear Deal – What Investors Need to Know

Mirion Technologies (MIR) Surges on $585 Million Nuclear Deal – What Investors Need to Know

A Nuclear Tech Stock on the Rise Mirion Technologies – a leader in radiation detection and measurement for the nuclear energy and medical sectors – has been making headlines with its stock price and strategic moves nasdaq.com. The Atlanta-based company’s shares have surged in 2025, vastly outperforming the broader market. This past week, Mirion’s stock rallied to fresh highs, buoyed by a flurry of positive news. On September 26, the stock opened nearly 7% higher (gapping up from a $21.43 prior close to $22.91) and continued climbing on heavy volume marketbeat.com. It finished the day around $23.7 – capping an ~11%
26 September 2025
··
Electronic Arts Stock Skyrockets on $50 Billion Buyout Rumors – Latest Price & Outlook (Sept 2025)

Electronic Arts Stock Skyrockets on $50 Billion Buyout Rumors – Latest Price & Outlook (Sept 2025)

Conclusion and Outlook Electronic Arts finds itself at a pivotal moment. On one hand, the company’s fundamentals are solid – it has globally popular franchises, a growing stream of digital and recurring revenues, and a history of profitability and shareholder returns. Its stock performance has reflected that steady strength, with significant gains over the past year and hitting new records. On the other hand, the sudden buyout talks signal that outside investors see even more value (or untapped potential) in EA than the public markets have recognized. A $50 billion deal, if it comes, could reward current shareholders with a rapid
26 September 2025
·
IREN Stock Today (Sept 26, 2025): AI Cloud Moonshot Meets Wall Street Reality Check—Is the Rally Just Pausing or Running Out of Fuel?

IREN Stock Today (Sept 26, 2025): AI Cloud Moonshot Meets Wall Street Reality Check—Is the Rally Just Pausing or Running Out of Fuel?

Key facts (as of 14:27 UTC, Sept 26, 2025) The story today (Sept 26, 2025) IREN shares are sharply lower after JPMorgan cut the stock to Underweight, even as it lifted its price target to $24 from $16—a call that implies sizable downside from recent levels following a torrid run. The note, summarized by multiple outlets, frames valuation as stretched relative to execution risk in high‑performance compute (HPC) build‑outs. Investing.com+1 At the same time, the AI narrative remains front and center. Industry trade press today reiterated IREN’s GPU expansion to 23k units and near‑term liquid‑cooled GB300 NVL72 deployments at its Prince George campus—details that buttress management’s push to turn spare power and real estate into
26 September 2025
Wall Street Rebounds: PCE In‑Line, Tariff Shock, and Fed‑Cut Bets — What It All Means (Sept. 26, 2025)

Wall Street Rebounds: PCE In‑Line, Tariff Shock, and Fed‑Cut Bets — What It All Means (Sept. 26, 2025)

Key facts (today) The U.S. stock market today — what moved prices 1) The data that mattered: PCE & spendingMarkets exhaled as the Fed’s preferred inflation gauge arrived exactly as expected: headline PCE +0.3% m/m (2.7% y/y), core +0.2% m/m (2.9% y/y). Treasury yields drifted lower, with the 10‑yr near 4.18% and the 2‑yr around 3.65%, signaling relief that there was no upside shock. Futures ticked higher on the print. Reuters “This should give some reassurances on the inflation side,” said Doug Beath of Wells Fargo Investment Institute. Reuters Consumer spending stayed solid in August, adding to this week’s Q2 GDP revision to 3.8%. The resilience complicates the Fed’s job (growth strong, inflation easing only slowly)
26 September 2025
·
Boeing Stock Soars on Mega-Orders but Faces Turbulence – Key 2025 Update

Boeing Stock Soars on Mega-Orders but Faces Turbulence – Key 2025 Update

Comprehensive Report on Boeing (BA) Stock as of September 26, 2025 Latest Stock Performance: Turbulence After a Climb After a solid run earlier in 2025, Boeing’s stock hit some turbulence in September. As of Sept 26, BA shares trade around $213–$214, roughly where they stood one month ago, but they have seesawed in between. Over the past week, the stock has been volatile yet range-bound: it opened the week near $217, dipped mid-week, and settled in the low $210s by Thursday’s close. This choppiness reflects a tug-of-war between positive news (like major aircraft orders) and lingering concerns (regulatory issues and
26 September 2025
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Stock Price and Recent Performance Pfizer’s stock has struggled in 2025, hovering near multi-year lows. At ~$23.60 per share in late September, PFE has declined about 9% since January, underperforming the S&P 500 (which is up modestly) and lagging the broader healthcare sector. Over the past 12 months, the stock is down roughly 18%. The 52-week high was $30.43, and shares now sit not far above their year’s low of $20.92 stockanalysis.com. By market capitalization (~$134 billion), Pfizer remains one of the world’s largest pharmaceutical companies, but its valuation has compressed significantly from pandemic-era peaks. This underperformance stems largely from
26 September 2025
··
SNAP Stock Just Got a 48‑Hour Jolt: India Creator Boom, New Sticker Push—and a $14B TikTok Twist Investors Can’t Ignore

SNAP Stock Just Got a 48‑Hour Jolt: India Creator Boom, New Sticker Push—and a $14B TikTok Twist Investors Can’t Ignore

Key facts (Sept 25–26, 2025): In‑depth report 1) What actually moved SNAP during Sept 25–26 Snap’s 1.34% gain to $8.33 on Sept 25 stood out in a weak tape, with ~247M shares trading (well above recent norms). The session left SNAP still well below its 52‑week peak ($13.28), but the resilience contrasts with declines across mega‑cap peers that day. That divergence sets up a near‑term narrative where company‑specific news (product rollouts, user‑growth geographies) can temporarily outweigh macro drag. MarketWatch+1 2) New product: Stickers—everywhere your audience chats Snap’s “Say it with a Sticker, Anywhere” update does three things investors should care about: 3) India momentum:
26 September 2025
·
RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

Key facts (Sept. 25–26, 2025) What just happened—and why it mattered Timeline (Sept. 24–26): Strategic aim: Management is steering fresh equity toward debt reduction, specifically highlighting the 8.00% notes due 2027. If all base proceeds went against those notes, annual interest expense could fall by ~$30.5M (and ~$35M with a fully exercised green‑shoe), before fees and taxes. The greenshoe option can also be used by underwriters for price stabilization in the aftermarket. deepwater.com Context from operations: Transocean’s Q2 2025 print showed $988M contract drilling revenue, 34.9% adjusted EBITDA margin, and $7.2B total backlog (July fleet status). Management emphasized balance‑sheet progress;
26 September 2025
·
PLUG Stock’s 48-Hour Whirlwind: ‘Street‑High’ $4 Target, Oppenheimer’s “first recovery step,” and a hydrogen‑sector reality check (Sept. 25–26, 2025)

PLUG Stock’s 48-Hour Whirlwind: ‘Street‑High’ $4 Target, Oppenheimer’s “first recovery step,” and a hydrogen‑sector reality check (Sept. 25–26, 2025)

Key facts (Sept. 25–26, 2025): What changed for PLUG on Sept. 25–26 A price‑target ceiling moved up. Craig‑Hallum raised its PLUG price target to $4, the highest on the Street, keeping a Buy stance. For a stock that closed Sept. 25 at $2.36, that’s a headline‑grabbing reset that can sway short‑term sentiment. Yahoo Finance Validating ops, cautiously on fundamentals. On Sept. 25, Oppenheimer reiterated Perform after touring Plug’s Georgia facility and suggested the upcoming quarter could mark “the first meaningful step in the platform’s recovery.” The note emphasized improved margins, a return to revenue growth, and progress on balance‑sheet options
26 September 2025
DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

Key facts (Sept. 25–26, 2025) In‑depth report What happened, and why it matters Datavault AI — the former WiSA Technologies that rebranded in February 2025 — secured a headline‑grabbing $150 million commitment from Scilex, delivered in Bitcoin. The company frames the deal as jet fuel for AI‑driven data monetization, saying the capital will build out a supercomputer footprint and launch independent data exchanges targeting high‑trust markets like biotech. Yahoo Finance+1 From a capital markets perspective, using BTC as settlement currency is unusual for listed U.S. tech micro‑caps and introduces crypto price risk alongside conventional equity‑financing risks (e.g., dilution, approval conditions).
26 September 2025
·····
AMPY Just Popped ~22% in a Day — Is Amplify Energy’s Rally For Real or a Head‑Fake? What the Fresh Data (Sept. 25–26) Really Shows

AMPY Just Popped ~22% in a Day — Is Amplify Energy’s Rally For Real or a Head‑Fake? What the Fresh Data (Sept. 25–26) Really Shows

In‑depth report What actually happened on Sept. 25–26 Price action: AMPY finished Sept. 25 at $5.84 (+21.67%), trading in a wide $5.17–$6.22 intraday range and posting ~13.5M shares in volume (vs. prior day ~0.54M). The step‑function move capped a three‑session upswing from $4.63 on Sept. 23. StockAnalysis Fresh discourse on Sept. 26: Before the market opened on Sept. 26, a widely read analysis argued that “large divestitures” could let Amplify “eliminate debt and focus on Beta development,” crystallizing the bull case investors have been nibbling at since August. Seeking Alpha Not a sector wave: The move occurred on a day
26 September 2025
·
SPRC Rockets 59% After “Quantum Leap”: What Really Drove SciSparc’s Two‑Day Surge (Sept. 25–26) — And What Comes Next

SPRC Rockets 59% After “Quantum Leap”: What Really Drove SciSparc’s Two‑Day Surge (Sept. 25–26) — And What Comes Next

Key facts (Sept. 25–26, 2025) What happened — and why it matters SciSparc’s new program aims to apply quantum algorithms to hard problems in protein folding and protein–ligand interactions, with the goal of more precise simulations that speed discovery in neurological and rare diseases. The board authorized creating a wholly‑owned Israeli subsidiary to run the effort and to pursue IP around the methods. GlobeNewswire The announcement comes alongside leadership changes disclosed in the same 6‑K: Amitay Weiss (formerly chair) moves into the President role, while Itschak Shrem becomes Chairman. Those shifts predate the quantum news (Sept. 21 resolution) but land in the same reporting
26 September 2025
·
PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

Key facts (25–26 Sept 2025) What happened—and why it mattered UnitedHealthcare coverage win. On Sept. 25, Plus Therapeutics announced that UnitedHealthcare Insurance Company (UNH) granted national coverage for its CNSide® CSF Tumor Cell Enumeration LDT for metastatic CNS cancer, effective Sept. 15. The deal potentially opens access to more than 51 million members nationwide and positions CNSide as a covered testing service for specialists treating leptomeningeal metastases (LM)—a devastating complication of advanced cancers. GlobeNewswire What the test does. The CNSide platform supports rapid diagnosis, treatment monitoring and guidance in LM. Plus Therapeutics reports >11,000 tests performed across 120+ institutions since
26 September 2025
·
Forza Horizon 6 Speeds Into Japan – Release Window, New Features & Everything We Know

Forza Horizon 6 Goes Full Send: Japan Setting, 2026 Launch, ‘Biggest Map Yet,’ PS5 Post‑Launch—All the Breaking News From Sept 25–26, 2025

Key facts (Sept 25–26, 2025) The announcement: what Xbox and Playground confirmed Xbox lifted the wraps on FH6 at Tokyo Game Show 2025 with a short cinematic that nods to prior Horizon locales before panning up to Mount Fuji, confirming Japan as the next Horizon festival site and 2026 as the release window. PC Gamer+1 On timing and platforms, Microsoft’s official FAQ is explicit: Xbox Series X|S and PC first in 2026; PS5 post‑launch. It also reiterates Game Pass day one, with Cloud Gaming access. Forza Support “For a long time, Japan has been top of Horizon fans’ wish lists,” says art director Don Arceta, calling the country’s cars, music, and fashion a
26 September 2025
·
Tariff Shock and Fed Jitters: Asian Markets Stumble as Rally Meets Reality

Tariff Shock and Fed Jitters: Asian Markets Stumble as Rally Meets Reality

Key Facts and Headlines September 25, 2025 – Cautious Optimism Before the Storm Asian markets were mostly steady on Thursday as investors navigated mixed signals from central banks and awaited key U.S. data releases. Japan’s Nikkei 225 edged up 0.3% to 45,755, recovering from early losses abcnews.go.com. Optimism in Tokyo was underpinned by hopes that the Bank of Japan would maintain its ultra-easy policy: fresh data showed Tokyo consumer inflation at 2.5% in September, below forecasts (2.8%) abcnews.go.com. While still above the BoJ’s 2% target, the cooler-than-expected price rise eased pressure for immediate tightening. This spurred bets that the BoJ
26 September 2025
·
1 … 1,157 1,158 1,159 1,160 1,161 … 1,172

Stock Market Today

Go toTop